Company profile: Aitia
1.1 - Company Overview
Company description
- Provider of Causal AI and digital twin-based drug discovery solutions. Offers Gemini Digital Twins—computational disease models that simulate genetic and molecular interactions to identify novel drug targets and patient subpopulations—and Causal AI Drug Discovery leveraging multi-omic data to accelerate development of new therapies for neurodegenerative diseases and oncology.
Products and services
- Causal AI Drug Discovery: Multi-omic system that utilizes causal AI to accelerate discovery and development of new therapeutics for neurodegenerative diseases and oncology by integrating diverse omic datasets
- Gemini Digital Twins: Computational representations of disease that simulate genetic and molecular interactions to reveal novel drug targets and stratify patient subpopulations for precision development
- Causal AI & Digital Twin Application: Digital twin–enabled practice applying causal AI and twin methodologies to discover the next generation of breakthrough drugs
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Aitia
Tahoe Bio
HQ: United States
Website
- Description: Provider of AI-powered tools that simulate human cell responses to guide drug discovery, including Mosaic for generating large-scale single-cell datasets and high-resolution in vivo phenotypic and transcriptomic profiling, single-cell RNA pooling to analyze drug action across diverse patients, and in vivo drug-cell interaction studies; initial applications in oncology; open-sources the Tahoe-100M dataset.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tahoe Bio company profile →
Protein Mechanics
HQ: United States
Website
- Description: Provider of cross-disciplinary computational techniques to accelerate drug discovery and design, offering novel methods that enable physically accurate modeling of biomolecular systems at unprecedented speeds, with the aim of making in silico biology an everyday tool for medical researchers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Protein Mechanics company profile →
Akcelis
HQ: Belgium
Website
- Description: Provider of patient management services, initially focused on digital patient recruitment for clinical trials; founded in 2015 by Nathalie Niclaus and Barbara D’haene. Headquartered in Belgium, offering services throughout Europe, and developed its own patient management to facilitate these services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Akcelis company profile →
VersaTrial
HQ: United States
Website
- Description: Provider of SaaS software that accelerates clinical research by addressing inefficiencies between pharma companies and their clinical trial site partners, helping shorten timelines, lower costs, and improve the experience for clinical staff and patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VersaTrial company profile →
Arxspan
HQ: United States
Website
- Description: Provider of a platform-independent suite of applications with US cloud-based web-delivery for project based research and development collaboration in the pharmaceutical, biotechnology, or chemistry industry, enabling tracking of internal research, management of incoming CRO data, and integration with existing enterprise knowledge management tools via a web-based user interface.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arxspan company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Aitia
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Aitia
2.2 - Growth funds investing in similar companies to Aitia
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Aitia
4.2 - Public trading comparable groups for Aitia
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →